Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure. / Gillespie, Matthew J; McElhinney, Doff B; Kreutzer, Jacqueline; Hellenbrand, William E; El-Said, Howaida; Ewert, Peter; Rhodes, John F; Søndergaard, Lars; Jones, Thomas K.

I: Annals of Thoracic Surgery, Bind 100, Nr. 3, 09.2015, s. 996-1003.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Gillespie, MJ, McElhinney, DB, Kreutzer, J, Hellenbrand, WE, El-Said, H, Ewert, P, Rhodes, JF, Søndergaard, L & Jones, TK 2015, 'Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure', Annals of Thoracic Surgery, bind 100, nr. 3, s. 996-1003. https://doi.org/10.1016/j.athoracsur.2015.04.108

APA

Gillespie, M. J., McElhinney, D. B., Kreutzer, J., Hellenbrand, W. E., El-Said, H., Ewert, P., Rhodes, J. F., Søndergaard, L., & Jones, T. K. (2015). Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure. Annals of Thoracic Surgery, 100(3), 996-1003. https://doi.org/10.1016/j.athoracsur.2015.04.108

Vancouver

Gillespie MJ, McElhinney DB, Kreutzer J, Hellenbrand WE, El-Said H, Ewert P o.a. Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure. Annals of Thoracic Surgery. 2015 sep.;100(3):996-1003. https://doi.org/10.1016/j.athoracsur.2015.04.108

Author

Gillespie, Matthew J ; McElhinney, Doff B ; Kreutzer, Jacqueline ; Hellenbrand, William E ; El-Said, Howaida ; Ewert, Peter ; Rhodes, John F ; Søndergaard, Lars ; Jones, Thomas K. / Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure. I: Annals of Thoracic Surgery. 2015 ; Bind 100, Nr. 3. s. 996-1003.

Bibtex

@article{9fb6aaf48d4644c1b968eb8198c00c84,
title = "Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure",
abstract = "BACKGROUND: Right ventricular outflow tract (RVOT) conduit dysfunction is a limitation of the Ross procedure. Transcatheter pulmonary valve replacement (TPVR) could alter the impact of conduit dysfunction and the risk-benefit balance for the Ross procedure.METHODS: Retrospective review of databases from 3 prospective Melody TPV (Medtronic Inc, Minneapolis, MN) trials.RESULTS: Among 358 patients who were catheterized with the intent to implant a Melody TPV for RVOT conduit stenosis or regurgitation (PR) as part of 3 prospective multicenter studies, 67 (19%) had a prior Ross procedure. Of these, 56 (84%) received a Melody valve; in 5 of the 11 patients who did not, the implant was aborted due to concern for coronary artery compression, and 1 implanted patient required emergent surgery for left coronary compression. The RVOT gradient decreased from a median 38 mm Hg to 13.5 mm Hg (p < 0.001). There was no or trivial PR in all but 4 patients, in whom it was mild. At a median follow-up of 4.0 years, 1 patient died from sepsis. Twelve patients underwent 14 transcatheter (n = 8) or surgical (n = 6) TPV reinterventions for obstruction with stent fracture (n = 9), endocarditis with conduit obstruction (n = 3), or reoperation (n = 2). Freedom from TPV explant was 89% ± 5% at 4 years. Among patients who did not undergo reintervention for obstruction, there was no change in RVOT gradient over time, and all but 1 patient had mild or less PR at last follow-up.CONCLUSIONS: The TPVR with the Melody valve provides acceptable early outcomes and durable valve function in the majority of Ross patients. Recurrent RVOT obstruction associated with stent fracture was the main reason for reintervention. Coronary compression is not uncommon in Ross patients and should be assessed prior to TPVR.",
keywords = "Adult, Cardiac Catheterization, Cardiac Surgical Procedures, Heart Valve Prosthesis Implantation, Humans, Postoperative Complications, Pulmonary Valve, Retrospective Studies, Ventricular Outflow Obstruction, Young Adult",
author = "Gillespie, {Matthew J} and McElhinney, {Doff B} and Jacqueline Kreutzer and Hellenbrand, {William E} and Howaida El-Said and Peter Ewert and Rhodes, {John F} and Lars S{\o}ndergaard and Jones, {Thomas K}",
note = "Copyright {\textcopyright} 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.",
year = "2015",
month = sep,
doi = "10.1016/j.athoracsur.2015.04.108",
language = "English",
volume = "100",
pages = "996--1003",
journal = "The Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier",
number = "3",

}

RIS

TY - JOUR

T1 - Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure

AU - Gillespie, Matthew J

AU - McElhinney, Doff B

AU - Kreutzer, Jacqueline

AU - Hellenbrand, William E

AU - El-Said, Howaida

AU - Ewert, Peter

AU - Rhodes, John F

AU - Søndergaard, Lars

AU - Jones, Thomas K

N1 - Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

PY - 2015/9

Y1 - 2015/9

N2 - BACKGROUND: Right ventricular outflow tract (RVOT) conduit dysfunction is a limitation of the Ross procedure. Transcatheter pulmonary valve replacement (TPVR) could alter the impact of conduit dysfunction and the risk-benefit balance for the Ross procedure.METHODS: Retrospective review of databases from 3 prospective Melody TPV (Medtronic Inc, Minneapolis, MN) trials.RESULTS: Among 358 patients who were catheterized with the intent to implant a Melody TPV for RVOT conduit stenosis or regurgitation (PR) as part of 3 prospective multicenter studies, 67 (19%) had a prior Ross procedure. Of these, 56 (84%) received a Melody valve; in 5 of the 11 patients who did not, the implant was aborted due to concern for coronary artery compression, and 1 implanted patient required emergent surgery for left coronary compression. The RVOT gradient decreased from a median 38 mm Hg to 13.5 mm Hg (p < 0.001). There was no or trivial PR in all but 4 patients, in whom it was mild. At a median follow-up of 4.0 years, 1 patient died from sepsis. Twelve patients underwent 14 transcatheter (n = 8) or surgical (n = 6) TPV reinterventions for obstruction with stent fracture (n = 9), endocarditis with conduit obstruction (n = 3), or reoperation (n = 2). Freedom from TPV explant was 89% ± 5% at 4 years. Among patients who did not undergo reintervention for obstruction, there was no change in RVOT gradient over time, and all but 1 patient had mild or less PR at last follow-up.CONCLUSIONS: The TPVR with the Melody valve provides acceptable early outcomes and durable valve function in the majority of Ross patients. Recurrent RVOT obstruction associated with stent fracture was the main reason for reintervention. Coronary compression is not uncommon in Ross patients and should be assessed prior to TPVR.

AB - BACKGROUND: Right ventricular outflow tract (RVOT) conduit dysfunction is a limitation of the Ross procedure. Transcatheter pulmonary valve replacement (TPVR) could alter the impact of conduit dysfunction and the risk-benefit balance for the Ross procedure.METHODS: Retrospective review of databases from 3 prospective Melody TPV (Medtronic Inc, Minneapolis, MN) trials.RESULTS: Among 358 patients who were catheterized with the intent to implant a Melody TPV for RVOT conduit stenosis or regurgitation (PR) as part of 3 prospective multicenter studies, 67 (19%) had a prior Ross procedure. Of these, 56 (84%) received a Melody valve; in 5 of the 11 patients who did not, the implant was aborted due to concern for coronary artery compression, and 1 implanted patient required emergent surgery for left coronary compression. The RVOT gradient decreased from a median 38 mm Hg to 13.5 mm Hg (p < 0.001). There was no or trivial PR in all but 4 patients, in whom it was mild. At a median follow-up of 4.0 years, 1 patient died from sepsis. Twelve patients underwent 14 transcatheter (n = 8) or surgical (n = 6) TPV reinterventions for obstruction with stent fracture (n = 9), endocarditis with conduit obstruction (n = 3), or reoperation (n = 2). Freedom from TPV explant was 89% ± 5% at 4 years. Among patients who did not undergo reintervention for obstruction, there was no change in RVOT gradient over time, and all but 1 patient had mild or less PR at last follow-up.CONCLUSIONS: The TPVR with the Melody valve provides acceptable early outcomes and durable valve function in the majority of Ross patients. Recurrent RVOT obstruction associated with stent fracture was the main reason for reintervention. Coronary compression is not uncommon in Ross patients and should be assessed prior to TPVR.

KW - Adult

KW - Cardiac Catheterization

KW - Cardiac Surgical Procedures

KW - Heart Valve Prosthesis Implantation

KW - Humans

KW - Postoperative Complications

KW - Pulmonary Valve

KW - Retrospective Studies

KW - Ventricular Outflow Obstruction

KW - Young Adult

U2 - 10.1016/j.athoracsur.2015.04.108

DO - 10.1016/j.athoracsur.2015.04.108

M3 - Journal article

C2 - 26190388

VL - 100

SP - 996

EP - 1003

JO - The Annals of Thoracic Surgery

JF - The Annals of Thoracic Surgery

SN - 0003-4975

IS - 3

ER -

ID: 162853703